BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL

SAN MATEO, Calif.–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the …

Continue

Do you trust this headline?

Based on recent headline ratings, 82% of this readership currently trusts the local media, which has an average score of 80% regionally and is currently trending positivepositive.

82%

Media Trust Score82%

Read All

In

News